The cholesterol transport inhibitor U18666A inhibits type I feline coronavirus infection
In conclusion, these findings demonstrate that NPC1 plays an important role in type I FCoV infection. U18666A or other cholesterol transport inhibitor may be considered as the antiviral drug for the treatment of cats with FIP.
Source: Antiviral Therapy - Category: Virology Source Type: research
More News: Antiviral Therapy | Cholesterol | Coronavirus | Niemann-Pick Disease | Peritonitis | Study | Virology